Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Prostatic Neoplasms × Dosage Forms × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Neurofibromatosis 1 1 Leukemia, Myeloid, Acute 1 Advanced Solid Tumors 1

Interventions

Prednisone 96 Docetaxel 78 Leuprolide 69 Abiraterone Acetate 60 enzalutamide 57 Goserelin 41 bicalutamide 40 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37 Radiotherapy 32 apalutamide 21 abiraterone 20 gallium 68 PSMA-11 19 Gonadotropin-Releasing Hormone 19 sipuleucel-T 18 luprolide acetate gel depot 18 Magnetic Resonance Spectroscopy 17 Triptorelin Pamoate 16 Radiosurgery 16 Androgen Antagonists 16 cabazitaxel 15 Radiotherapy, Intensity-Modulated 13 pembrolizumab 12 Prednisolone 12 Dexamethasone 12 Brachytherapy 12 cabozantinib 11 Radiation 11 Dutasteride 11 Carboplatin 11 radium Ra 223 dichloride 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00913068 2021-10-04

TAP

Nova Scotia Health Authority

Phase NA Completed

110 enrolled 5 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡